Although in our EVs from eribulin-treated cancer cells, ABCC11 mRNA was not up-regulated, we found that both ABCC2 (log2FC = +4.570, about 23 times more) and ABCG2 (log2FC = +2.366, about 5 times more) were up-regulated. The gene discussed is ABCC2; the disease is cancer.